Tiflet-5 Tablet contains Tofacitinib (5 mg), an advanced oral Janus kinase (JAK) inhibitor used in the treatment of autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by targeting key enzymes involved in the inflammatory process, offering relief from joint pain, swelling, and stiffness.
Key Benefits of Tiflet-5 Tablet
1. Reduces joint inflammation – Relieves symptoms of rheumatoid and psoriatic arthritis.
2. Manages autoimmune flares – Controls disease activity in chronic inflammatory conditions.
3. Improves mobility & comfort – Reduces pain and stiffness, improving quality of life.
4. Oral targeted therapy – Convenient alternative to injectable biologics.
How Does Tiflet-5 Tablet Work?
Tofacitinib (5 mg): A selective JAK inhibitor that interferes with signaling pathways involved in inflammation and immune response, helping to regulate the overactive immune system in autoimmune diseases.
